Improving Identification and Child-Focused Collaborative Care for Children of Parents With a Mental Illness in Tyrol, Austria

ConclusionThe research project aims to directly improve identification and support of vulnerable children across selected regions in Austria, and by doing so, improve the health and well-being of future Austrian generations while breaking the cycle of intergenerational transfer of adverse childhood experiences. The described project underwent a rigorous public review process (https://ois.lbg.ac.at/en/methods-projects/crowdsourcing-research-questions-in-science) with different stakeholders as well as people with lived experience and scientific experts of the field having reviewed our proposal (https://ois.lbg.ac.at/en/methods-projects/ideas-lab). This ensures high acceptance and most likely high probability of implementation of our approach, a highly relevant fact for sustained impact. Further, the research group is genuinely interdisciplinary with researchers from public health, (clinical) psychology, economics, linguistics, and implementation sciences thus combining not only different expertise but also perspectives that are crucial concerning cooperation and collaboration. We believe that the research findings from the described public health intervention will also be relevant for health care providers and policymakers in other countries, and the international research community.Ethics StatementThe study is performed according to the Declaration of Helsinki and its later amendments and was approved by the Human Research Ethics Committee of Monash University Melbourne, Austr...
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research

Related Links:

To what extent does male alcohol consumption impact a couple's time to pregnancy?Human Reproduction
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news
As coronavirus cases surge across the US, doctors and nurses are telling CNN there's still a dire shortage of protective equipment, especially masks. Critics say the Trump administration isn't properly using a law that could help alleviate the shortage. CNN's Drew Griffin reports
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
Middle-aged people in the United States are in worse health than those living in England, and the disparities are larger for low income individuals, according to a new study. This gap could point to why Covid-19 has had a more devastating impact on low income Americans.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
Basel, 14 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its investigational CD20xCD3 T-cell engaging bispecific mosunetuzumab has been granted Breakthrough Therapy Designation (BTD) by the US Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma who have received at least two prior systemic therapies.“We are pleased that the FDA has granted Breakthrough Therapy Designation to mosunetuzumab, recognising the promising early efficacy data for this molecule and the remaining unmet need in follicular lymphoma,” said Levi Gar...
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news
The Trump administration is pushing to fully reopen schools across the nation despite growing coronavirus numbers, but health officials say plans need to be made to keep families safe. Dr. Dyan Hes, a pediatrician and founder of Gramercy Pediatrics in New York City, joins CBSN's "Red&Blue" to discuss.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
             Basel, 14 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Blueprint Medicines Corporation (NASDAQ:BPMC), today announced the signing of a licensing and collaboration agreement providing exclusive rights to Roche for global co-development and commercialisation outside the United States (US), excluding Greater China*. In the US, Genentech, a member of the Roche Group, will obtain co-commercialisation rights to pralsetinib, Blueprint Medicine ’s investigational, once-daily oral precision therapy for the treatment of people with RET-altered ...
Source: Roche Media News - Category: Pharmaceuticals Source Type: news
Source: Reuters: Health - Category: Consumer Health News Source Type: news
Source: Reuters: Health - Category: Consumer Health News Source Type: news
Source: Reuters: Health - Category: Consumer Health News Source Type: news
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Academia | Addiction | Alcoholism | Anxiety | Australia Health | Austria Health | Child Abuse | Child Development | Children | Conferences | Denmark Health | Depression | Disability | Economics | Education | Employment | Environmental Health | Epidemiology | Genetics | Germany Health | Health Management | Information Technology | International Medicine & Public Health | Learning | Legislation | Marburg Virus | Medical Ethics | Men | Netherlands Health | Norway Health | Nursing | Parenting | Pediatrics | Perinatology & Neonatology | Politics | Postnatal Depression | Pregnancy | Primary Care | Psychiatry | Psychology | Psychotherapy | Rural Health | Schizophrenia | Science | Statistics | Study | Sweden Health | Switzerland Health | Teachers | Training | UK Health | Universities & Medical Training | USA Health | Websites | Workshops